Literature DB >> 11318257

Douching and endometritis: results from the PID evaluation and clinical health (PEACH) study.

R B Ness1, D E Soper, R L Holley, J Peipert, H Randall, R L Sweet, S J Sondheimer, S L Hendrix, S L Hillier, A Amortegui, G Trucco, D C Bass.   

Abstract

BACKGROUND: Douching has been related to risk of pelvic inflammatory disease (PID). GOAL: To examine the association between douching and PID in a large, multicenter, clinical trial of PID after adjustment for race/ethnicity. STUDY
DESIGN: Interviews were conducted with 654 women who had signs and symptoms of PID. Vaginal Gram stains and upper genital tract pathology/cultures were obtained from all the women. Women with evidence of plasma cell endometritis and/or gonococcal or chlamydial upper genital tract infections were compared with women who had neither endometritis nor upper genital tract infection.
RESULTS: Women with endometritis or upper genital tract infection were more likely to have douched more than once a month or within 6 days of enrollment than women who never douched. These associations remained after adjustment for confounding factors, after analysis of black women only; and among women with normal or intermediate vaginal flora but not bacterial vaginosis.
CONCLUSION: Among a predominantly black group of women with clinical PID, frequent and recent douching was associated with endometritis and upper genital tract infection.

Entities:  

Mesh:

Year:  2001        PMID: 11318257     DOI: 10.1097/00007435-200104000-00010

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  12 in total

Review 1.  Vaginal douching: evidence for risks or benefits to women's health.

Authors:  Jenny L Martino; Sten H Vermund
Journal:  Epidemiol Rev       Date:  2002       Impact factor: 6.222

2.  Prevalence and correlates of recent vaginal douching among African American adolescent females.

Authors:  R J Diclemente; A M Young; J L Painter; G M Wingood; E Rose; J M Sales
Journal:  J Pediatr Adolesc Gynecol       Date:  2011-11-03       Impact factor: 1.814

3.  Prevalence of bacterial vaginosis and vaginal flora changes in peri- and postmenopausal women.

Authors:  Sabina Cauci; Silvia Driussi; Davide De Santo; Paola Penacchioni; Teresa Iannicelli; Paolo Lanzafame; Francesco De Seta; Franco Quadrifoglio; Domenico de Aloysio; Secondo Guaschino
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

Review 4.  Obstetric and gynecological diseases and complications resulting from vaginal dysbacteriosis.

Authors:  Stefan Miladinov Kovachev
Journal:  Microb Ecol       Date:  2014-04-08       Impact factor: 4.552

5.  Vaginal Immunity in Bacterial Vaginosis.

Authors:  Sabina Cauci
Journal:  Curr Infect Dis Rep       Date:  2004-12       Impact factor: 3.725

6.  Does douching increase risk for sexually transmitted infections? A prospective study in high-risk adolescents.

Authors:  Cynthia S Tsai; Bryan E Shepherd; Sten H Vermund
Journal:  Am J Obstet Gynecol       Date:  2008-07-30       Impact factor: 8.661

7.  Vaginal douching among Latinas: practices and meaning.

Authors:  M Diane McKee; María Baquero; Matthew R Anderson; Adelyn Alvarez; Alison Karasz
Journal:  Matern Child Health J       Date:  2008-02-23

8.  Intravaginal Practices in Female Sex Workers in Cambodia: A Qualitative Study.

Authors:  Thanh Cong Bui; Ly Thi-Hai Tran; Leng Bun Hor; Michael E Scheurer; Damon J Vidrine; Christine M Markham
Journal:  Arch Sex Behav       Date:  2016-01-07

Review 9.  Pelvic inflammatory disease: current concepts in pathogenesis, diagnosis and treatment.

Authors:  Caroline Mitchell; Malavika Prabhu
Journal:  Infect Dis Clin North Am       Date:  2013-10-31       Impact factor: 5.982

10.  Exploring the Vaginal Microbiome and Intravaginal Practices in Postmenopausal Women.

Authors:  Gaea A Daniel; Yingtian Hu; Despina Tsementzi; C Ileen Jhaney; Yi-Juan Hu; Katherine A Yeager; Jinbing Bai; Mary Dolan; Deborah W Bruner
Journal:  Nurs Res       Date:  2021 Set/Oct 01       Impact factor: 2.381

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.